Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2013
12/19/2013US20130338137 Substituted annellated pyrimidines and use thereof
12/18/2013EP2059519B1 Nitrogen-containing heterocyclic compounds and methods of use thereof
12/18/2013EP1855529B1 Spiroketal-substituted cyclic ketoenols
12/18/2013CN103459370A Method for producing 1-H-pyrrolidine-2,4-dione derivatives
12/18/2013CN103458898A Autophagy inducing compound and use thereof
12/18/2013CN103450208A Antibacterial compound as well as preparation method and application thereof
12/18/2013CN103450207A Preparation method of Pachystaudine
12/18/2013CN102285992B Dihydroporphin (III) chelates having plant growth regulating activity and use thereof as plant growth regulator
12/18/2013CN102216305B Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes
12/18/2013CN102070644B Method for preparing camptothecin derivatives and intermediates thereof
12/18/2013CN101679354B Triazinedione derivatives as GABAB receptor modulators
12/18/2013CN101337900B Method of synthesizing camptothecin-relating compounds
12/17/2013US8609860 Acid-labile trigger units
12/17/2013US8609858 Spiro derivatives of parthenin as novel anticancer agents
12/17/2013US8609844 Method for extracting and purifying bisbenzylisoquinolines
12/17/2013US8609716 Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof
12/17/2013US8609686 Substituted azabicyclic compounds and the use thereof
12/17/2013US8609675 Fused Tricyclic Compounds as novel mTOR inhibitors
12/17/2013US8609653 Azaindole compounds and methods for treating HIV
12/17/2013CA2691961C Catecholamine derivatives and prodrugs thereof
12/17/2013CA2633481C Preventive or therapeutic agent for acute renal failure
12/17/2013CA2617953C Method of acylating maytansinol with chiral amino acids
12/17/2013CA2527583C Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/12/2013WO2013184902A1 Chemical transformations of (-)-codeine to afford derivatives of codeine and morphine thereof
12/12/2013WO2013181741A1 Imino compounds as protecting agents against ultraviolet radiations
12/12/2013US20130331564 Epothilone derivatives
12/12/2013US20130331410 2,3-DIHYDROFURO[2,3-c]PYRIDIN-2-YLPIPERIDINE DERIVATIVES
12/12/2013US20130331372 Cyclic Amine Substituted Oxazolidinone CETP Inhibitor
12/12/2013CA2875165A1 Imino compounds as protecting agents against ultraviolet radiations
12/11/2013EP2671882A1 pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
12/11/2013CN103443103A Novel Fusarisetin compounds, and use thereof
12/11/2013CN103443097A Fused dihydrofurans as GPR119 modulators for the treatment of diabetes, obesity and related disorders
12/11/2013CN103436253A Rhodamine fluorescent probe for detecting ferrous ion, and preparation method thereof
12/11/2013CN103435626A Preparation method of corynoloxine
12/11/2013CN103435625A Red light emission rhodamine-based ionic fluorescent probe and application thereof
12/11/2013CN102603759B Camptothecin E ring analogues and applications thereof as drugs
12/11/2013CN102603756B Rhodamine B sulfide compound and preparation method and applications of Rhodamine B sulfide compound
12/11/2013CN101622255B Spirocyclic cyclohexane derivatives
12/10/2013US8604050 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
12/10/2013US8604029 2-[(2-substituted)-indolizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
12/10/2013CA2633940C Preventive or therapeutic agent for cardiac dysfunction or myocardial injury caused by ischemia or ischemia reperfusion
12/10/2013CA2623117C Novel crystal forms of irinotecan hydrochloride
12/05/2013WO2013180478A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
12/05/2013WO2013179645A1 Organic-electroluminescent-element material, and organic electroluminescent element using same
12/05/2013US20130324571 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
12/05/2013US20130324568 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12/05/2013US20130324525 Substituted heterocyclic compounds
12/05/2013US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
12/05/2013US20130324494 Novel pharmaceutical compounds
12/04/2013EP2668191A2 Benzofuro[3,2-c]pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
12/04/2013EP2668168A1 COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION
12/04/2013EP2668162A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
12/04/2013EP2668158A1 Method for producing 1-h-pyrrolidine-2,4-dione derivatives
12/04/2013CN103429569A New azaspirodecanone compounds
12/04/2013CN103421015A Switch-type ferric ion fluorescence probe and preparation method thereof
12/04/2013CN103421014A Synthesis method of galanthamine
12/04/2013CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine
12/04/2013CN103420988A Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/04/2013CN102432618B Preparation process for separating and purifying strychnine from total alkali of nux vomica
12/03/2013US8598343 Process for preparing a 2-alkynyl substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
12/03/2013US8598342 Methods and compounds for antimicrobial intervention
12/03/2013US8598215 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
12/03/2013US8598198 Nucleic acid binding dyes and uses therefor
12/03/2013US8598197 CDK inhibitors
12/03/2013US8598193 Polycyclic agents for the treatment of respiratory syncytial virus infections
12/03/2013US8598164 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
12/03/2013CA2611312C Organic compounds
12/03/2013CA2603509C Crystal form of asenapine maleate
12/03/2013CA2516660C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/2013
11/28/2013WO2013174780A1 Substituted dipyridylamines and uses thereof
11/28/2013WO2013152065A3 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
11/28/2013US20130317207 Carboxy x rhodamine analogs
11/28/2013US20130317044 Novel carboxylic acid derivatives, their preparation and use
11/28/2013US20130317014 Inhibitors of beta-secretase
11/28/2013US20130316961 Treatment of mecp-2 associated disorders
11/27/2013EP2666768A2 Condensed-cyclic compound and organic light-emitting diode comprising the same
11/27/2013EP2665719A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
11/27/2013CN103415507A 3-amino-pyridines as GPBAR1 agonists
11/27/2013CN103415504A 2-acyloxy-pyrrolin-4-ones
11/27/2013CN103409135A Rhodamine fluorescent molecular probe using quinoline derivative as identification group and synthesis method thereof
11/27/2013CN103408559A Camptothecin and rapid synthesis method of derivative of camptothecin
11/27/2013CN103408557A Indolizidine alkaloid as well as preparation method and application thereof
11/27/2013CN103408556A Method for extracting elatine
11/27/2013CN103408555A Rhodamine B derivative, its preparation and application
11/27/2013CN103408554A Hypertensive activity reducing pyrrole coumarins compound and preparation method thereof
11/27/2013CN102351871B Method for synthesizing spiro hydroxy indole compounds
11/27/2013CN102311447B Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor
11/26/2013US8592588 Process to prepare camptothecin derivatives
11/26/2013US8592424 Topical regional neuro-affective therapy
11/26/2013CA2532982C Thienopyridine and furopyridine kinase inhibitors
11/21/2013WO2013173488A1 Antiviral compounds inhibitors of hcv ns5b
11/21/2013WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013170774A1 Acetylene derivative having antineoplastic activity
11/21/2013WO2013170770A1 Acetylene derivatives having antitumor activity
11/21/2013US20130310411 Novel acridine derivatives
11/21/2013US20130310389 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
11/21/2013US20130310364 Compositions and methods for inhibition of the jak pathway
11/21/2013US20130309196 Antiviral compounds
11/20/2013EP2265616B1 Furo-and thieno[3,2-c]pyridines
11/20/2013EP1709009B1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 298